The expression of functional toll-like receptor 4 is associated with proliferation and maintenance of stem cell phenotype in endothelial progenitor cells (EPCs)

Journal of Cellular Biochemistry

Volumn 111, Issue 1, 2010, Pages 179-186

  He, Jin ^a,b   Xiao, Zhilin ^a   Chen, Xiaobin ^a   Chen, Meifang ^a   Fang, Li ^a   Yang, Mei ^a   Lv, Qingshan ^a   Li, Yuehui ^c   Li, Guancheng ^c   Hu, Jinyue ^d   Xie, Xiumei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Province People's Hospital   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Cell surface markers; Lipopolysaccharide; Progenitor endothelial cells; Proliferation; Toll like receptor 4

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD14 ANTIGEN; CELL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STEM CELL;

APOPTOSIS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CYTOKINES; ENDOTHELIAL CELLS; FETAL BLOOD; HUMANS; IMMUNITY, INNATE; PHENOTYPE; SIGNAL TRANSDUCTION; STEM CELLS; TOLL-LIKE RECEPTOR 4;

EID: 77957126896     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22686     Document Type: Article

References (42)

1. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4:499-511.
2. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
3. Amcheslavsky A, Bar-Shavit Z. 2007. Toll-like receptor 9 ligand blocks osteoclast differentiation through induction of phosphatase. J Bone Miner Res 22:1301-1310.
4. Aoki M, Yasutake M, Murohara T. 2004. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 22:994-1002.
5. Bi Y, Seabold JM, Kaar SG, Ragab AA, Goldberg VM, Anderson JM, Greenfield EM. 2001. Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 16:2082-2091.
6. Brass DM, Hollingsworth JW, Cinque M, Li Z, Potts E, Toloza E, Foster WM, Schwartz DA. 2008. Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. Am J Respir Cell Mol Biol 39:584-590.
7. Braunwald E. 1997. Shattuck lecture-cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med 337:1360-1369. (Pubitemid 27467771)
8. Breslow JL. 1997. Cardiovascular disease burden increases, NIH funding decreases. Nat Med 3:600-601.
9. Burnham EL, Taylor WR, Quyyumi AA, Rojas M, Brigham KL, Moss M. 2005. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 172:854-860.
10. Capolunghi F, Cascioli S, Giorda E, Rosado MM, Plebani A, Auriti C, Seganti G, Zuntini R, Ferrari S, Cagliuso M, Quinti I, Carsetti R. 2008. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 180:800-808.
11. Chang EJ, Kim HJ, Ha J, Kim HJ, Ryu J, Park KH, Kim UH, Lee ZH, Kim HM, Fisher DE, Kim HH. 2007. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J Cell Sci 120:166-176.
12. Chen GY, Shiah HC, Su HJ, Chen CY, Chuang YJ, Lo WH, Huang JL, Chuang CK, Hwang SM, Hu YC. 2009. Baculovirus transduction of mesenchymal stem cells triggers the Toll-like receptor 3 pathway. J Virol 83:10548-10556.
13. Covacu R, Arvidsson L, Andersson A, Khademi M, Erlandsson-Harris H, Harris RA, Svensson MA, Olsson T, Brundin L. 2009. TLR activation induces TNF-alpha production from adult neural stem/progenitor cells. J Immunol 182:6889-6895.
14. Damico RL, Chesley A, Johnston L, Bind EP, Amaro E, Nijmeh J, Karakas B, Welsh L, Pearse DB, Garcia JG, Crow MT. 2008. Macrophage migration inhibitory factor governs endothelial cell sensitivity to LPS-induced apoptosis. Am J Respir Cell Mol Biol 39:77-85.
15. Dauphinee SM, Karsan A. 2006. Lipopolysaccharide signaling in endothelial cells. Lab Invest 86:9-22.
16. De Luca K, Frances-Duvert V, Asensio MJ, Ihsani R, Debien E, Taillardet M, Verhoeyen E, Bella C, Lantheaume S, Genestier L, Defrance T. 2009. The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia 23:2063-2074.
17. Dzau VJ, Gnecchi M, Pachori AS, Morello F, Melo LG. 2005. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 46:7-18. (Pubitemid 40946479)
18. Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M. 2001. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: Role of NF-kappa B activation. J Immunol 166:2018-2024.
19. Genestier L, Taillardet M, Mondiere P, Gheit H, Bella C, Defrance T. 2007. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol 178:7779-7786.
20. Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ, Pratt RE, Mulligan RC, Dzau VJ. 2003. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: Implications for cell-based vascular therapy. Circulation 108:2710-2715.
21. Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Seidinger D, Weigel G, Schwarzinger I, Wolozcszuk W, Steiner G, Smolen JS. 2005. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 111:204-211.
22. Ha H, Lee JH, Kim HN, Kwak HB, Kim HM, Lee SE, Rhee JH, Kim HH, Lee ZH. 2008. Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-beta. J Immunol 180:1382-1389.
23. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531-4537.
24. Hristov M, Weber C. 2004. Endothelial progenitor cells: Characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 8:498-508. (Pubitemid 44145482)
25. Kaiser WJ, Kaufman JL, Offermann MK. 2004. IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA. J Immunol 172:1699-1710.
26. Kong D, Melo LG, Mangi AA, Zhang L, Lopez-Ilasaca M, Perrella MA, Liew CC, Pratt RE, Dzau VJ. 2004. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109:1769-1775.
27. Lee SH, Hong B, Sharabi A, Huang XF, Chen SY. 2009. Embryonic stem cells and mammary luminal progenitors directly sense and respond to microbial products. Stem Cells 27:1604-1615.
28. Libby P, Sukhova G, Lee RT, Liao JK. 1997. Molecular biology of atherosclerosis. Int J Cardiol 62(Suppl 2): S23-S29.
29. Liotta F, Angeli R, Cosmi L, Fili L, Manuelli C, Frosali F, Mazzinghi B, Maggi L, Pasini A, Lisi V, Santarlasci V, Consoloni L, Angelotti ML, Romagnani P, Parronchi P, Krampera M, Maggi E, Romagnani S, Annunziato F. 2008. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 26:279-289.
30. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, Klersy C, Pecci A, Moratti R, Tavazzi L. 2005. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105:199-206.
31. Mayr FB, Spiel AO, Leitner JM, Firbas C, SieghartW, Jilma B. 2007. Effects of low dose endotoxemia on endothelial progenitor cells in humans. Atherosclerosis 195:e202-e206. (Pubitemid 47561970)
32. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, Imaizumi T. 2000. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105:1527-1536.
33. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. 1998. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 18:842-851.
34. Palliser D, Huang Q, Hacohen N, Lamontagne SP, Guillen E, Young RA, Eisen HN. 2004. A role for Toll-like receptor 4 in dendritic cell activation and cytolytic CD8+ T cell differentiation in response to a recombinant heat shock fusion protein. J Immunol 172:2885-2893.
35. Rodriguez S, Chora A, Goumnerov B, Mumaw C, Goebel WS, Fernandez L, Baydoun H, HogenEsch H, Dombkowski DM, Karlewicz CA, Rice S, Rahme LG, Carlesso N. 2009. Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood 114:4064-4076.
36. Ross R. 1999. Atherosclerosis - An inflammatory disease. N Engl J Med 340:115-126.
37. Rui L, Healy JI, Blasioli J, Goodnow CC. 2006. ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation. J Immunol 177:5337-5346. (Pubitemid 44527606)
38. Sioud M, Floisand Y. 2007. TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response. Eur J Immunol 37:2834-2846.
39. Skokos D, Nussenzweig MC. 2007. CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J Exp Med 204:1525-1531.
40. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. 2001. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1-E7.
41. Werner N, Nickenig G. 2006. Influence of cardiovascular risk factors on endothelial progenitor cells: Limitations for therapy? Arterioscler Thromb Vasc Biol 26:257-266.
42. Yamada M, Kubo H, Ishizawa K, Kobayashi S, Shinkawa M, Sasaki H. 2005. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: Evidence that bone marrow derived cells contribute to lung repair. Thorax 60:410-413. (Pubitemid 40685824)